(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.00%6.34B | 10.96%4.83B | 12.81%3.56B | 8.23%2.15B | 4.03%5.81B | 5.96%4.35B | 0.90%3.15B | 9.04%1.98B | 12.82%5.59B | 13.71%4.1B |
Special items of operating revenue | ---- | 24.38%72.64M | ---- | 19.10%24.38M | ---- | -41.61%58.4M | ---- | -36.83%20.47M | ---- | 7.48%100.03M |
Operating income | 9.00%6.34B | 11.14%4.9B | 12.81%3.56B | 8.34%2.17B | 4.03%5.81B | 4.83%4.41B | 0.90%3.15B | 8.24%2B | 12.82%5.59B | 13.55%4.2B |
Cost of sales | -7.65%-5.41B | ---- | -12.88%-2.95B | ---- | -8.88%-5.02B | ---- | -2.27%-2.62B | ---- | -14.74%-4.61B | ---- |
Operating expenses | -7.65%-5.41B | -10.58%-4.05B | -12.88%-2.95B | -9.00%-1.85B | -8.88%-5.02B | -7.09%-3.66B | -2.27%-2.62B | -11.59%-1.7B | -14.74%-4.61B | -16.68%-3.42B |
Gross profit | 17.55%930.64M | 13.89%850.97M | 12.45%603.87M | 4.65%318.13M | -18.91%791.71M | -5.00%747.21M | -5.30%537M | -7.32%303.99M | 4.55%976.29M | 1.71%786.53M |
Selling expenses | -1.90%-203.29M | -6.04%-186.04M | -7.20%-125.27M | -3.97%-45.24M | 6.11%-199.5M | -5.38%-175.44M | -5.21%-116.85M | 0.79%-43.51M | 2.22%-212.49M | -19.84%-166.48M |
Administrative expenses | -28.90%-519.08M | -18.71%-385.08M | -37.58%-186.3M | -22.13%-110.35M | 16.03%-402.7M | -0.19%-324.4M | 39.13%-135.41M | 10.84%-90.35M | 11.84%-479.6M | -8.19%-323.79M |
Research and development expenses | ---- | ---259.43K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit from asset sales | ---- | 125.38%402.83K | ---- | --5.01K | ---- | -2,528.56%-1.59M | ---- | ---- | ---- | 168.40%65.35K |
Revaluation surplus | ---- | 12.95%-177.62M | ---- | 75.67%-38.79M | ---- | 11.82%-204.05M | ---- | -2.15%-159.44M | ---- | -472.07%-231.4M |
-Changes in the fair value of other assets | ---- | 12.95%-177.62M | ---- | 75.67%-38.79M | ---- | 11.82%-204.05M | ---- | -2.15%-159.44M | ---- | -472.07%-231.4M |
Impairment and provision | 69.23%-27.54M | 235.73%4.6M | 232.66%2.23M | 23.05%-1.63M | -149.84%-89.52M | -30.88%-3.39M | 79.07%-1.68M | 47.38%-2.12M | -45.52%-35.83M | -646.63%-2.59M |
-Other impairment is provision | 69.23%-27.54M | 235.73%4.6M | 232.66%2.23M | 23.05%-1.63M | -149.84%-89.52M | -30.88%-3.39M | 79.07%-1.68M | 47.38%-2.12M | -45.52%-35.83M | -646.63%-2.59M |
Operating interest expense | ---- | ---- | 0.48%-161.46M | ---- | ---- | ---- | 4.92%-162.23M | ---- | -2.14%-339.49M | ---- |
Special items of operating profit | -12.11%208.64M | 669.00%457.24M | -8.94%-30.56M | 265.83%307.72M | 110.56%237.4M | -89.40%59.46M | -142.67%-28.05M | -243.59%-185.57M | -81.56%112.75M | 64.50%561.04M |
Operating profit | 15.41%389.38M | 566.28%546.91M | 10.51%102.52M | 330.31%423.7M | 1,459.32%337.39M | -86.46%82.08M | -23.07%92.77M | -225.54%-183.97M | -94.93%21.64M | -2.04%606.28M |
Financing cost | 9.74%-294.69M | -52.41%-134.81M | ---- | 1.07%-79.87M | ---326.5M | 63.96%-88.45M | ---- | -20.70%-80.73M | ---- | 8.31%-245.41M |
Share of profits of associates | 10,494.80%324.2M | ---- | 543.94%539.52M | ---- | -99.35%3.06M | ---- | -154.88%-121.53M | ---- | 34.26%469.47M | ---- |
Share of profit from joint venture company | -29.29%51.29M | ---- | ---- | ---- | 2,476.48%72.53M | ---- | ---- | ---- | 39.29%2.82M | ---- |
Special items of earning before tax | 82.56%-67.3M | 839.48%17.91M | ---- | 167.30%1.14M | ---385.96M | -78.25%1.91M | ---- | 205.22%427.02K | ---- | 172.85%8.77M |
Earning before tax | 234.52%402.88M | 9,734.82%430.01M | 2,332.40%642.04M | 230.53%344.97M | -160.63%-299.49M | -101.21%-4.46M | -108.41%-28.76M | -431.19%-264.28M | -36.55%493.92M | 8.97%369.63M |
Tax | -318.52%-99.25M | -7.34%-62.15M | -120.29%-74.25M | -1,254.64%-41.59M | 144.64%45.42M | -17.15%-57.9M | 13.65%-33.7M | -126.73%-3.07M | 44.74%-101.75M | -36.61%-49.42M |
After-tax profit from continuing operations | 219.51%303.64M | 689.88%367.86M | 1,008.99%567.79M | 213.48%303.37M | -164.78%-254.07M | -119.48%-62.36M | -120.62%-62.46M | -392.88%-267.35M | -34.02%392.18M | 5.67%320.21M |
Earning after tax | 219.51%303.64M | 689.88%367.86M | 1,008.99%567.79M | 213.48%303.37M | -164.78%-254.07M | -119.48%-62.36M | -120.62%-62.46M | -392.88%-267.35M | -34.02%392.18M | 5.67%320.21M |
Minority profit | 16.01%91.09M | 10.27%94.66M | 2.25%90.27M | -24.73%43.64M | -11.59%78.52M | -12.94%85.85M | 2.49%88.29M | -16.76%57.98M | 12.27%88.82M | -0.54%98.61M |
Profit attributable to shareholders | 163.91%212.54M | 284.33%273.2M | 416.76%477.52M | 179.84%259.73M | -209.64%-332.59M | -166.88%-148.21M | -169.52%-150.75M | -1,604.39%-325.33M | -41.12%303.36M | 8.69%221.6M |
Basic earnings per share | 163.64%0.07 | 280.00%0.09 | 420.00%0.16 | 179.85%0.088 | -210.00%-0.11 | -166.58%-0.05 | -171.43%-0.05 | -1,609.59%-0.1102 | -41.18%0.1 | 8.68%0.0751 |
Diluted earnings per share | 163.64%0.07 | 280.00%0.09 | 420.00%0.16 | 179.85%0.088 | -210.00%-0.11 | -166.58%-0.05 | -171.43%-0.05 | -1,609.59%-0.1102 | -41.18%0.1 | 8.68%0.0751 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data